Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tanya Dorff
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- National Taiwan University Hospital
Taipei, Taiwan
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- University of Colorado
Denver, Colorado, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Northshore University Healthsystem-Glenbrook Hospital
Glenview, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard
Fort Wayne, Indiana, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2012
- Primary completion
- 8 Aug 2017
- Completion
- 8 Aug 2017
- Last update posted
- 28 Aug 2018
- Registered enrollment
- 59
- Registry id
- NCT01727089
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.